Indivior PLC (INDV) | Financial Analysis & Statements
Indivior PLC Mid-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
358.0M
Gross Profit
291.0M
81.28%
Operating Income
83.0M
23.18%
Net Income
102.0M
28.49%
EPS (Diluted)
$0.79
Balance Sheet Metrics
Total Assets
1.2B
Total Liabilities
1.3B
Shareholders Equity
-99.0M
Cash Flow Metrics
Operating Cash Flow
85.0M
Free Cash Flow
-245.0M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Indivior PLC Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1.2B | 1.2B | 1.1B | 901.0M | 791.0M |
| Cost of Goods Sold | 246.0M | 231.0M | 186.0M | 159.0M | 127.0M |
| Gross Profit | 993.0M | 957.0M | 907.0M | 742.0M | 664.0M |
| Gross Margin % | 80.1% | 80.6% | 83.0% | 82.4% | 83.9% |
| Operating Expenses | |||||
| Research & Development | 97.0M | 107.0M | 106.0M | 72.0M | 52.0M |
| Selling, General & Administrative | 634.0M | 618.0M | 811.0M | 763.0M | 431.0M |
| Other Operating Expenses | -3.0M | 4.0M | - | - | - |
| Total Operating Expenses | 728.0M | 729.0M | 917.0M | 835.0M | 483.0M |
| Operating Income | 265.0M | 228.0M | -8.0M | -91.0M | 181.0M |
| Operating Margin % | 21.4% | 19.2% | -0.7% | -10.1% | 22.9% |
| Non-Operating Items | |||||
| Interest Income | 22.0M | 23.0M | 43.0M | 18.0M | 1.0M |
| Interest Expense | 45.0M | 41.0M | 37.0M | 29.0M | 26.0M |
| Other Non-Operating Income | -3.0M | - | - | - | - |
| Pre-tax Income | 239.0M | 14.0M | 1.0M | -95.0M | 190.0M |
| Income Tax | 29.0M | 11.0M | -1.0M | -42.0M | -15.0M |
| Effective Tax Rate % | 12.1% | 78.6% | -100.0% | 0.0% | -7.9% |
| Net Income | 210.0M | 3.0M | 2.0M | -53.0M | 205.0M |
| Net Margin % | 16.9% | 0.3% | 0.2% | -5.9% | 25.9% |
| Key Metrics | |||||
| EBITDA | 307.0M | 280.0M | 62.0M | -51.0M | 206.0M |
| EPS (Basic) | $1.68 | $-0.36 | $0.01 | $-0.38 | $1.40 |
| EPS (Diluted) | $1.64 | $-0.36 | $0.01 | $-0.38 | $1.35 |
| Basic Shares Outstanding | 125000000 | 132309000 | 137306000 | 139012000 | 145659800 |
| Diluted Shares Outstanding | 125000000 | 132309000 | 137306000 | 139012000 | 145659800 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Indivior PLC Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 195.0M | 319.0M | 316.0M | 774.0M | 1.1B |
| Short-term Investments | 0 | 1.0M | 94.0M | 119.0M | - |
| Accounts Receivable | 253.0M | 254.0M | 254.0M | 220.0M | 202.0M |
| Inventory | 155.0M | 178.0M | 142.0M | 114.0M | 95.0M |
| Other Current Assets | 13.0M | 53.0M | 434.0M | 13.0M | 14.0M |
| Total Current Assets | 652.0M | 839.0M | 1.3B | 1.3B | 1.4B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 26.0M | 39.0M | 0 | 0 | 0 |
| Goodwill | 4.0M | 9.0M | 242.0M | 70.0M | 82.0M |
| Intangible Assets | - | 5.0M | 232.0M | 70.0M | 82.0M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 350.0M | 28.0M | 9.0M | 18.0M | 84.0M |
| Total Non-Current Assets | 550.0M | 481.0M | 691.0M | 510.0M | 388.0M |
| Total Assets | 1.2B | 1.3B | 2.0B | 1.8B | 1.8B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 48.0M | 63.0M | 39.0M | 33.0M | 26.0M |
| Short-term Debt | 39.0M | 28.0M | 12.0M | 11.0M | 11.0M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | -1.0M | 10.0M | 125.0M | 79.0M | 61.0M |
| Total Current Liabilities | 914.0M | 939.0M | 1.3B | 1.0B | 804.0M |
| Non-Current Liabilities | |||||
| Long-term Debt | 312.0M | 347.0M | 270.0M | 266.0M | 275.0M |
| Deferred Tax Liabilities | - | - | - | - | - |
| Other Non-Current Liabilities | 22.0M | 16.0M | 367.0M | 428.0M | 474.0M |
| Total Non-Current Liabilities | 386.0M | 728.0M | 649.0M | 699.0M | 825.0M |
| Total Liabilities | 1.3B | 1.7B | 2.0B | 1.7B | 1.6B |
| Equity | |||||
| Common Stock | 62.0M | 62.0M | 68.0M | 68.0M | 70.0M |
| Retained Earnings | -243.0M | -454.0M | 1.2B | 1.3B | 1.4B |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | -99.0M | -348.0M | 0 | 51.0M | 203.0M |
| Key Metrics | |||||
| Total Debt | 351.0M | 375.0M | 282.0M | 277.0M | 286.0M |
| Working Capital | -262.0M | -100.0M | -42.0M | 240.0M | 640.0M |
Balance Sheet Composition
Indivior PLC Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 210.0M | 2.0M | -4.0M | -85.0M | 213.0M |
| Depreciation & Amortization | 20.0M | - | - | - | - |
| Stock-Based Compensation | 26.0M | 24.0M | 22.0M | 16.0M | 11.0M |
| Working Capital Changes | 111.0M | 346.0M | -469.0M | 26.0M | -12.0M |
| Operating Cash Flow | 321.0M | 373.0M | -451.0M | -43.0M | 212.0M |
| Investing Activities | |||||
| Capital Expenditures | -66.0M | -29.0M | -8.0M | -5.0M | -4.0M |
| Acquisitions | 0 | 0 | -5.0M | 0 | 0 |
| Investment Purchases | -20.0M | -17.0M | -45.0M | -245.0M | 0 |
| Investment Sales | 20.0M | 117.0M | 129.0M | 27.0M | 0 |
| Investing Cash Flow | -65.0M | 70.0M | -53.0M | -223.0M | -4.0M |
| Financing Activities | |||||
| Share Repurchases | -11.0M | -173.0M | -33.0M | -90.0M | -101.0M |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | 0 | 332.0M | 0 | 0 | 250.0M |
| Debt Repayment | -17.0M | -240.0M | -12.0M | -3.0M | -236.0M |
| Financing Cash Flow | -30.0M | -102.0M | -41.0M | -91.0M | -86.0M |
| Free Cash Flow | -94.0M | 5.0M | -368.0M | -10.0M | 319.0M |
| Net Change in Cash | 226.0M | 341.0M | -545.0M | -357.0M | 122.0M |
Cash Flow Trend
Indivior PLC Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
20.22
Forward P/E
9.60
Price to Book
-42.07
Price to Sales
3.26
PEG Ratio
0.02
Profitability Ratios
Profit Margin
16.95%
Operating Margin
37.15%
Return on Equity
-212.12%
Return on Assets
19.22%
Financial Health
Current Ratio
0.71
Debt to Equity
-3.55
Beta
1.20
Per Share Data
EPS (TTM)
$1.64
Book Value per Share
$-0.78
Revenue per Share
$9.91
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| INDV | 4.0B | 20.22 | -42.07 | -212.12% | 16.95% | -3.55 |
| Zoetis | 49.8B | 19.58 | 15.04 | 65.99% | 28.24% | 279.59 |
| Haleon Plc - ADR | 42.4B | 18.72 | 1.88 | 10.27% | 15.11% | 52.37 |
| Alkermes plc | 5.6B | 23.71 | 3.09 | 14.72% | 16.37% | 3.85 |
| Lantheus Holdings | 5.4B | 24.30 | 4.91 | 21.45% | 15.15% | 57.19 |
| Amneal | 4.2B | 63.23 | -57.42 | -101.02% | 2.39% | 45,095.52 |
Financial data is updated regularly. All figures are in the company's reporting currency.






